Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysis ; volume:20 ; number:1 ; day:3 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
Clinical proteomics ; 20, Heft 1 (3.8.2023), 1-12, 12.2023
- Creator
-
Marin, Lina M.
Katselis, George S.
Chumala, Paulos
Sanche, Stephen
Julseth, Lucas
Penz, Erika
Skomro, Robert
Siqueira, Walter L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12014-023-09417-w
- URN
-
urn:nbn:de:101:1-2023110110055511437440
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marin, Lina M.
- Katselis, George S.
- Chumala, Paulos
- Sanche, Stephen
- Julseth, Lucas
- Penz, Erika
- Skomro, Robert
- Siqueira, Walter L.
- SpringerLink (Online service)
Other Objects (12)
Saliva proteomics updates in biomedicine
Quantitative proteomics for identifying biomarkers for Rabies
ELISA detection of SARS-CoV-2 antibodies in saliva
Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis
Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
Quantitative proteomics for identifying biomarkers for tuberculous meningitis
Potential urine proteomics biomarkers for primary nephrotic syndrome
Proteomics, biomarkers, and HIV‐1: A current perspective
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
Postmortem proteomics to discover biomarkers for forensic PMI estimation
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
Saliva proteomics updates in biomedicine
Quantitative proteomics for identifying biomarkers for Rabies
ELISA detection of SARS-CoV-2 antibodies in saliva
Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis
Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
Quantitative proteomics for identifying biomarkers for tuberculous meningitis
Potential urine proteomics biomarkers for primary nephrotic syndrome
Proteomics, biomarkers, and HIV‐1: A current perspective
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
Postmortem proteomics to discover biomarkers for forensic PMI estimation
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
Saliva proteomics updates in biomedicine
Quantitative proteomics for identifying biomarkers for Rabies
ELISA detection of SARS-CoV-2 antibodies in saliva
Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis
Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
Quantitative proteomics for identifying biomarkers for tuberculous meningitis
Potential urine proteomics biomarkers for primary nephrotic syndrome
Proteomics, biomarkers, and HIV‐1: A current perspective
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection
Postmortem proteomics to discover biomarkers for forensic PMI estimation
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?